SKN | Latigo Biotherapeutics Targets Nasdaq Debut With Non-Opioid Pain Drug Pipeline
Latigo Biotherapeutics Inc. is moving ahead with a U.S. IPO as the clinical-stage biotechnology company seeks capital to advance its non-opioid pain medicines into...
SKN | Latigo Biotherapeutics Prices Upsized IPO at High End, Raising $346 Million for Non-Opioid Pain Drug Pipeline
Latigo Biotherapeutics has successfully priced its initial public offering (IPO) above its originally planned size, raising $346 million after pricing 19.2 million shares at...
SKN | Barrick Mining Shares Rise Ahead of Q2 Earnings as Investors Focus on Gold and Copper Outlook
Barrick Mining Corporation (NYSE: B) traded modestly higher ahead of its second-quarter 2026 earnings release, as investors assessed the company's exposure to strengthening precious...
SKN | Petrobras Reports Q2 Results as Production Strength and Energy Transition Investments Remain in Focus
Petrobras Delivers Second-Quarter Results
Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) released its second-quarter 2026 earnings as investors assessed the company's financial performance amid evolving...
SKN | River City Bank Prices Downsized $122 Million IPO Below Range as Regional Banking Sector Faces Valuation Pressure
River City Bank has priced its downsized initial public offering (IPO) at $45 per share, below its marketed range of $48 to $51, raising...